Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWQ203 is an imidazopyridine amide antibiotic.1 It is active against M. tuberculosis and M. ulcerans (MIC50s = 2.7 and 0.86 nM, respectively).1,2 Q203 binds to the oxidation site on mitochondrial complex III, also known as cytochrome bc1 complex, and disrupts ATP synthesis in M. tuberculosis (IC50 = 1.1 nM).1 It reduces bacterial load, as well as the number of lung colony forming units (CFUs) and granulomatous foci in a mouse model of M. tuberculosis infection when administered at a dose of 10 mg/kg for three days.
WARNING This product is not for human or veterinary use.
1. Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. Nat. Med. 19(9), 1157-1160 (2013).
2. Targeting the Mycobacterium ulcerans cytochrome bc1:aa3 for the treatment of Buruli ulcer. Nat. Commun. 9(1), 5370 (2018).